Estimates Revisions Joinn Laboratories(China)Co.,Ltd. Hong Kong S.E.
Stocks
6127
CNE100004BP3
Biotechnology & Medical Research
|
Delayed
Hong Kong S.E.
08:19:00 08/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 30.16 HKD | +2.24% |
|
-2.21% | +46.21% |
| 09-24 | Joinn Laboratories' Unit Subscribes to Asset Management Products for 540 Million Yuan | MT |
| 08-28 | Joinn Laboratories' H1 Attributable Profit Surges; Revenue Up | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
EBIT
Dividend / Share (DPS)
Data source:
Joinn Laboratories(China)Co.,Ltd.(603127)
Cash or Net Debt
- Stock Market
- Stocks
- 603127 Stock
- 6127 Stock
- Consensus Joinn Laboratories(China)Co.,Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
